| 000 | 01882 a2200529 4500 | ||
|---|---|---|---|
| 005 | 20250514014926.0 | ||
| 264 | 0 | _c20011205 | |
| 008 | 200112s 0 0 eng d | ||
| 022 | _a0735-1097 | ||
| 024 | 7 |
_a10.1016/s0735-1097(01)01565-0 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aCalnon, D A | |
| 245 | 0 | 0 |
_aPrognostic value of dobutamine stress technetium-99m-sestamibi single-photon emission computed tomography myocardial perfusion imaging: stratification of a high-risk population. _h[electronic resource] |
| 260 |
_bJournal of the American College of Cardiology _cNov 2001 |
||
| 300 |
_a1511-7 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Validation Study | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aBias |
| 650 | 0 | 4 |
_aCardiotonic Agents _xpharmacology |
| 650 | 0 | 4 |
_aCoronary Disease _xdiagnostic imaging |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 |
_aDobutamine _xpharmacology |
| 650 | 0 | 4 | _aDogs |
| 650 | 0 | 4 | _aDrug Interactions |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 | _aProportional Hazards Models |
| 650 | 0 | 4 |
_aRadiopharmaceuticals _xpharmacokinetics |
| 650 | 0 | 4 | _aReferral and Consultation |
| 650 | 0 | 4 | _aRisk Assessment |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 | _aSurvival Analysis |
| 650 | 0 | 4 |
_aTechnetium Tc 99m Sestamibi _xpharmacokinetics |
| 650 | 0 | 4 |
_aTomography, Emission-Computed, Single-Photon _xmethods |
| 700 | 1 | _aMcGrath, P D | |
| 700 | 1 | _aDoss, A L | |
| 700 | 1 | _aHarrell, F E | |
| 700 | 1 | _aWatson, D D | |
| 700 | 1 | _aBeller, G A | |
| 773 | 0 |
_tJournal of the American College of Cardiology _gvol. 38 _gno. 5 _gp. 1511-7 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0735-1097(01)01565-0 _zAvailable from publisher's website |
| 999 |
_c11607277 _d11607277 |
||